Body mass index at early adulthood, subsequent weight change and cancer incidence and mortality.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 24771654)

Published in Int J Cancer on May 08, 2014

Authors

Xuesong Han1, June Stevens, Kimberly P Truesdale, Patrick T Bradshaw, Anna Kucharska-Newton, Anna E Prizment, Elizabeth A Platz, Corinne E Joshu

Author Affiliations

1: Surveillance and Health Services Research Program, American Cancer Society, Atlanta, GA; Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Associated clinical trials:

Charge: A Text Messaging-based Weight Loss Intervention | NCT03254940

Articles cited by this

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol (1989) 37.83

A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr (1982) 17.28

Dual effects of weight and weight gain on breast cancer risk. JAMA (1997) 4.81

Growth patterns and the risk of breast cancer in women. N Engl J Med (2004) 4.78

The definition of weight maintenance. Int J Obes (Lond) (2006) 3.45

Alcohol intake in relation to diet and obesity in women and men. Am J Clin Nutr (1991) 3.20

The metabolic syndrome and risk of incident colorectal cancer. Cancer (2006) 2.16

A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.97

Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol (2002) 1.91

Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med (2006) 1.88

Body size at different periods of life and breast cancer risk. Am J Epidemiol (1988) 1.76

Body size and risk of breast cancer. Am J Epidemiol (1997) 1.63

Health behaviors of adults: United States, 1999-2001. Vital Health Stat 10 (2004) 1.63

Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J Natl Cancer Inst (2004) 1.60

Weight history and risk of endometrial cancer among Chinese women. Int J Epidemiol (2005) 1.58

Childhood growth and breast cancer. Am J Epidemiol (2004) 1.47

Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer (1999) 1.44

Examining breast cancer growth and lifestyle risk factors: early life, childhood, and adolescence. Clin Breast Cancer (2008) 1.43

Height and weight at various ages and risk of breast cancer. Ann Epidemiol (1992) 1.34

Body size across the life course, mammographic density, and risk of breast cancer. Am J Epidemiol (2011) 1.28

Obesity in youth and middle age and risk of colorectal cancer in men. Cancer Causes Control (1992) 1.27

Associations of weight, weight change, and body mass with breast cancer risk in Hispanic and non-Hispanic white women. Ann Epidemiol (2002) 1.23

Quetelet's index and risk of colon cancer in college alumni. J Natl Cancer Inst (1992) 1.22

Risk of breast cancer in young women in relation to body size and weight gain in adolescence and early adulthood. Br J Cancer (1999) 1.17

Relation between obesity and breast cancer in young women. Am J Epidemiol (1999) 1.14

Early body size and subsequent weight gain as predictors of breast cancer incidence (Iowa, United States). Cancer Causes Control (1995) 1.12

Effect of body size on breast-cancer risk among Japanese women. Int J Cancer (1999) 1.07

Alcohol consumption-associated breast cancer incidence and potential effect modifiers: the Japan Public Health Center-based Prospective Study. Int J Cancer (2010) 1.05

Long-term overweight and weight gain in early adulthood in association with risk of endometrial cancer. Int J Cancer (2011) 1.03

Young adulthood body mass index and risk of cancer in later adulthood: historical cohort study. Cancer Causes Control (2010) 0.98

Body size and incident colorectal cancer: a prospective study of older women. Cancer Prev Res (Phila) (2010) 0.98

Measured body mass index in adolescence and the incidence of colorectal cancer in a cohort of 1.1 million males. Cancer Epidemiol Biomarkers Prev (2011) 0.96

Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers. Obstet Gynecol (2011) 0.95

A prospective study of body mass, height, and smoking on the risk of colorectal cancer in women. Cancer Causes Control (1991) 0.93

Body fat, puberty and fertility. Biol Rev Camb Philos Soc (1984) 0.91

Age-related macular degeneration and cancer mortality in the atherosclerosis risk in communities study. Arch Ophthalmol (2007) 0.82

Relation between anthropometric indicators and risk of breast cancer among Australian women. Am J Epidemiol (1993) 0.77

Articles by these authors

Inflammation in prostate carcinogenesis. Nat Rev Cancer (2007) 9.08

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07

Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol (2013) 5.24

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02

C-reactive protein and the risk of incident colorectal cancer. JAMA (2004) 4.94

Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study. Circulation (2008) 4.84

Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the expert panel on population and prevention science). Circulation (2008) 4.62

Pathways: a school-based, randomized controlled trial for the prevention of obesity in American Indian schoolchildren. Am J Clin Nutr (2003) 4.53

Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49

Prevalence of hearing loss and differences by demographic characteristics among US adults: data from the National Health and Nutrition Examination Survey, 1999-2004. Arch Intern Med (2008) 4.40

Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev (2006) 4.02

Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer (2007) 3.77

China's transition: the effect of rapid urbanization on adult occupational physical activity. Soc Sci Med (2006) 2.99

Prevalence and risk factors for erectile dysfunction in the US. Am J Med (2007) 2.84

Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res (2002) 2.84

Promoting physical activity in middle school girls: Trial of Activity for Adolescent Girls. Am J Prev Med (2008) 2.78

Associations of whole-grain, refined-grain, and fruit and vegetable consumption with risks of all-cause mortality and incident coronary artery disease and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr (2003) 2.76

Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med (2004) 2.60

Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. J Clin Oncol (2005) 2.57

Prediction of mortality after radical prostatectomy by Charlson comorbidity index. Urology (2010) 2.54

Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study. J Natl Cancer Inst (2009) 2.50

The influence of statin medications on prostate-specific antigen levels. J Natl Cancer Inst (2008) 2.46

Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans. J Clin Endocrinol Metab (2007) 2.36

Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med (2008) 2.33

Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis (2004) 2.33

Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. J Urol (2006) 2.31

Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. Cancer Epidemiol Biomarkers Prev (2003) 2.26

The female-male disparity in obesity prevalence among black American young adults: contributions of sociodemographic characteristics of the childhood family. Am J Clin Nutr (2009) 2.24

Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. Cancer Res (2002) 2.24

Replacing caloric beverages with water or diet beverages for weight loss in adults: main results of the Choose Healthy Options Consciously Everyday (CHOICE) randomized clinical trial. Am J Clin Nutr (2012) 2.23

Pounds Off Digitally study: a randomized podcasting weight-loss intervention. Am J Prev Med (2009) 2.21

Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab (2006) 2.17

Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland. Am J Epidemiol (2004) 2.08

Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care (2007) 2.08

Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2006) 2.00

Risk factors for hearing loss in US adults: data from the National Health and Nutrition Examination Survey, 1999 to 2002. Otol Neurotol (2009) 1.99

Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev (2007) 1.97

Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining. Am J Pathol (2002) 1.95

A description of the social-ecological framework used in the trial of activity for adolescent girls (TAAG). Health Educ Res (2006) 1.93

Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev (2011) 1.86

Cadmium levels in urine and mortality among U.S. adults. Environ Health Perspect (2008) 1.79

Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst (2012) 1.79

The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev (2012) 1.75

A prospective study of statin drug use and lower urinary tract symptoms in older men. Am J Epidemiol (2013) 1.75

Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev (2003) 1.75

Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am J Clin Nutr (2002) 1.74

Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy. J Clin Oncol (2003) 1.74

RNASEL Arg462Gln polymorphism and prostate cancer in PLCO. Prostate (2007) 1.74

Epidemiologic musing on statin drugs in the prevention of advanced prostate cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.74

School-level intraclass correlation for physical activity in adolescent girls. Med Sci Sports Exerc (2004) 1.73

Ejaculation frequency and subsequent risk of prostate cancer. JAMA (2004) 1.71

C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer (2008) 1.71

Objectively measured physical activity in sixth-grade girls. Arch Pediatr Adolesc Med (2006) 1.70

Physical activity interventions in Latin America: a systematic review. Am J Prev Med (2008) 1.69

Ideal cardiovascular health is inversely associated with incident cancer: the Atherosclerosis Risk In Communities study. Circulation (2013) 1.68

Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. Am J Pathol (2003) 1.67

Body composition and overweight prevalence in 1704 schoolchildren from 7 American Indian communities. Am J Clin Nutr (2003) 1.64

Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer Prev Res (Phila) (2010) 1.62

Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev (2014) 1.61

TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas. Mod Pathol (2009) 1.61

A novel role of myosin VI in human prostate cancer. Am J Pathol (2006) 1.59

Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Cancer (2010) 1.59

Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas. Am J Surg Pathol (2011) 1.58

Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial. Int J Cancer (2009) 1.56

Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment. J Cell Biochem (2004) 1.56

Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy. Cancer Epidemiol Biomarkers Prev (2005) 1.55

Obesity in American-Indian children: prevalence, consequences, and prevention. Prev Med (2003) 1.53

Cardiovascular Disease Mortality Among Breast Cancer Survivors. Epidemiology (2016) 1.52

Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk. Prostate (2007) 1.52

Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res (2006) 1.52

Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control (2009) 1.52

Choline metabolism and risk of breast cancer in a population-based study. FASEB J (2008) 1.51

The relation between birth weight and intima-media thickness in middle-aged adults. Epidemiology (2004) 1.51

What can geography tell us about prostate cancer? Am J Prev Med (2006) 1.51

Telomere length as a risk factor for hereditary prostate cancer. Prostate (2013) 1.50

Functional independence after major abdominal surgery in the elderly. J Am Coll Surg (2004) 1.50

Invited Commentary: Limitations and Usefulness of the Metabolically Healthy Obesity Phenotype. Am J Epidemiol (2015) 1.48

General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.47

Missing stage and grade in Maryland prostate cancer surveillance data, 1992-1997. Am J Prev Med (2006) 1.46

Calcium intake and prostate cancer risk in a long-term aging study: the Baltimore Longitudinal Study of Aging. Urology (2002) 1.46

Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II. Prostate (2009) 1.45

Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men. Cancer Causes Control (2009) 1.43

Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarrays. Prostate (2004) 1.43

Oral health and risk for head and neck squamous cell carcinoma: the Carolina Head and Neck Cancer Study. Cancer Causes Control (2010) 1.41

Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial. Int J Cancer (2010) 1.41

Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative. Circ Cardiovasc Qual Outcomes (2014) 1.41

Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort. Cancer Causes Control (2009) 1.40

Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey. Am J Epidemiol (2004) 1.38

Validity of self-reported dietary intake at school meals by American Indian children: the Pathways Study. J Am Diet Assoc (2004) 1.36

Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer. Mod Pathol (2012) 1.35

Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr (2004) 1.35

Cigarette smoking and prostate cancer recurrence after prostatectomy. J Natl Cancer Inst (2011) 1.34

Meat and dairy consumption and subsequent risk of prostate cancer in a US cohort study. Cancer Causes Control (2007) 1.34

Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III). Prostate (2005) 1.34

Obesity, adipokines, and prostate cancer in a prospective population-based study. Cancer Epidemiol Biomarkers Prev (2006) 1.33

Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol (2010) 1.33

The metabolic syndrome is associated with reduced risk of prostate cancer. Am J Epidemiol (2006) 1.32